Patents by Inventor Anthony DiRenzo

Anthony DiRenzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060223990
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Application
    Filed: September 9, 2005
    Publication date: October 5, 2006
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 7041817
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: May 9, 2006
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Publication number: 20050074760
    Abstract: An enzymatic nucleic acid molecule comprising a 5?- and/or a 3?-cap structure, wherein said structure is not a 5?-5?-linked inverted nucleotide or a 3?-3?-linked inverted nucleotide.
    Type: Application
    Filed: May 6, 2003
    Publication date: April 7, 2005
    Inventors: Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Thale Jarvis, Nassim Usman, Anthony DiRenzo, Francine Wincott
  • Patent number: 6649751
    Abstract: Provided is a method for purification and synthesis of RNA molecules that have at least one chemical modification.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: November 18, 2003
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Publication number: 20030166917
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Application
    Filed: May 28, 2002
    Publication date: September 4, 2003
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 6586238
    Abstract: An enzymatic nucleic acid molecule comprising a 5′- and/or a 3′-cap structure, wherein said structure is not a 5′-5′-linked inverted nucleotide or a 3′-3′-linked inverted nucleotide.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: July 1, 2003
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Thale Jarvis, Nassim Usman, Anthony DiRenzo, Francine Wincott
  • Publication number: 20030088087
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Application
    Filed: August 30, 2002
    Publication date: May 8, 2003
    Applicant: Ribozyme Pharmaceuticals, Inc.
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 6469158
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: October 22, 2002
    Assignee: Ribozyme Pharmaceuticals, Incorporated
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 6437117
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Grant
    Filed: July 27, 1999
    Date of Patent: August 20, 2002
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 5998203
    Abstract: An enzymatic nucleic acid molecule comprising a 5'- and/or a 3'-cap structure, wherein said structure is not a 5'-5'-linked inverted nucleotide or a 3'-3'-linked inverted nucleotide.
    Type: Grant
    Filed: April 16, 1996
    Date of Patent: December 7, 1999
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Thale Jarvis, Nassim Usman, Anthony DiRenzo, Francine Wincott